Abpro Bio Co., Ltd. (KOSDAQ: 195990)
South Korea
· Delayed Price · Currency is KRW 476.00
-3.00 (-0.63%)
Oct 11, 2024, 3:00 PM KST
Abpro Bio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 18,585 | 25,375 | 22,112 | 32,914 | 35,797 | 31,930 | Upgrade
|
| Other Revenue | 0 | - | -0 | - | - | - | Upgrade
|
| Revenue | 18,585 | 25,375 | 22,112 | 32,914 | 35,797 | 31,930 | Upgrade
|
| Revenue Growth (YoY) | -28.17% | 14.76% | -32.82% | -8.05% | 12.11% | -45.75% | Upgrade
|
| Cost of Revenue | 19,281 | 24,107 | 20,493 | 28,986 | 30,195 | 44,610 | Upgrade
|
| Gross Profit | -696.17 | 1,269 | 1,619 | 3,928 | 5,602 | -12,680 | Upgrade
|
| Selling, General & Admin | 8,800 | 8,269 | 8,544 | 7,848 | 4,974 | 10,222 | Upgrade
|
| Research & Development | 559.94 | 573.04 | 879.91 | 562.3 | 519.15 | 1,985 | Upgrade
|
| Other Operating Expenses | 376.49 | 323.52 | 251.64 | 433.14 | 335.11 | 337.22 | Upgrade
|
| Operating Expenses | 11,995 | 11,444 | 12,813 | 9,261 | 7,493 | 17,469 | Upgrade
|
| Operating Income | -12,691 | -10,175 | -11,193 | -5,333 | -1,891 | -30,149 | Upgrade
|
| Interest Expense | -2,565 | -2,341 | -4,591 | -6,859 | -4,946 | -10,510 | Upgrade
|
| Interest & Investment Income | 347.01 | 301.52 | 167.66 | 576.37 | 468.58 | 537.8 | Upgrade
|
| Earnings From Equity Investments | -8,288 | -9,377 | 4,219 | -5,876 | -12,984 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 2,588 | 520.54 | 1,760 | 2,388 | -1,179 | 306.59 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,366 | -1,015 | -867.14 | 8,613 | -19,725 | 3,721 | Upgrade
|
| EBT Excluding Unusual Items | -19,242 | -22,086 | -10,505 | -6,491 | -40,257 | -36,093 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.45 | 16.29 | 2,520 | - | - | 2,569 | Upgrade
|
| Gain (Loss) on Sale of Assets | -252.41 | -2,559 | 328.51 | 650.04 | -190.14 | -58.29 | Upgrade
|
| Asset Writedown | -683.27 | -1,029 | -487.48 | -3,834 | -759.42 | -3,516 | Upgrade
|
| Pretax Income | -20,174 | -25,658 | -8,145 | -9,675 | -41,207 | -37,098 | Upgrade
|
| Income Tax Expense | -11.89 | 84.12 | - | 64.59 | 3,548 | -2,601 | Upgrade
|
| Earnings From Continuing Operations | -20,162 | -25,742 | -8,145 | -9,740 | -44,755 | -34,498 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -775.31 | -16,862 | -5,145 | Upgrade
|
| Net Income to Company | -20,162 | -25,742 | -8,145 | -10,515 | -61,617 | -39,643 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 484.68 | 2,645 | 1,773 | Upgrade
|
| Net Income | -20,162 | -25,742 | -8,145 | -10,030 | -58,972 | -37,869 | Upgrade
|
| Net Income to Common | -20,162 | -25,742 | -8,145 | -10,030 | -58,972 | -37,869 | Upgrade
|
| Shares Outstanding (Basic) | 283 | 278 | 268 | 252 | 213 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 283 | 278 | 268 | 270 | 214 | 131 | Upgrade
|
| Shares Change (YoY) | 3.17% | 3.72% | -0.50% | 25.82% | 64.14% | 64.11% | Upgrade
|
| EPS (Basic) | -71.26 | -92.51 | -30.36 | -39.85 | -276.73 | -290.07 | Upgrade
|
| EPS (Diluted) | -71.27 | -92.51 | -30.36 | -43.31 | -304.43 | -292.34 | Upgrade
|
| Free Cash Flow | -10,926 | -6,011 | -12,593 | -2,762 | 2,490 | -113.57 | Upgrade
|
| Free Cash Flow Per Share | -38.62 | -21.60 | -46.94 | -10.24 | 11.62 | -0.87 | Upgrade
|
| Gross Margin | -3.75% | 5.00% | 7.32% | 11.93% | 15.65% | -39.71% | Upgrade
|
| Operating Margin | -68.29% | -40.10% | -50.62% | -16.20% | -5.28% | -94.42% | Upgrade
|
| Profit Margin | -108.49% | -101.44% | -36.83% | -30.47% | -164.74% | -118.60% | Upgrade
|
| Free Cash Flow Margin | -58.79% | -23.69% | -56.95% | -8.39% | 6.96% | -0.36% | Upgrade
|
| EBITDA | -10,798 | -8,305 | -9,791 | -2,708 | 5,357 | -25,686 | Upgrade
|
| EBITDA Margin | -58.10% | -32.73% | -44.28% | -8.23% | 14.96% | -80.44% | Upgrade
|
| D&A For EBITDA | 1,893 | 1,870 | 1,402 | 2,625 | 7,248 | 4,463 | Upgrade
|
| EBIT | -12,691 | -10,175 | -11,193 | -5,333 | -1,891 | -30,149 | Upgrade
|
| EBIT Margin | -68.29% | -40.10% | -50.62% | -16.20% | -5.28% | -94.42% | Upgrade
|
| Advertising Expenses | - | 1.92 | 297.47 | 163.47 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.